Drugs / pLADD
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03189030 | May 2017 → Oct 2019 | colorectal cancer | Aduro Biotech, Inc. | Terminated | No outcome recorded Stop: Business |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | pLADD | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03189030 ↗ |
| Modality | Other / unclassified | “pLADD-based immunotherapy” NCT03189030 ↗ |
| Route | Intravenous | “via IV infusion” NCT03189030 ↗ |